The promoters of Thyrocare, country's largest thyroid testing laboratory chain, are looking to dilute up to 10 per cent stake in the company to finance the growth plans of its new arm, a top executive of the firm told VCCircle.Nueclear Healthcare Ltd, a division of Thyrocare Group, is planning to ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
